The addition of pembrolizumab (PD-L1) to trastuzumab and first-line chemotherapy in the phase III KEYNOTE-811 [18] clinical trial showed an increase in objective response rate (ORR) of 74.4% versus 51.9% for trastuzumab and chemotherapy alone for GC. Currently an unmet need is the ...
The addition of pembrolizumab (PD-L1) to trastuzumab and first-line chemotherapy in the phase III KEYNOTE-811 [18] clinical trial showed an increase in objective response rate (ORR) of 74.4% versus 51.9% for trastuzumab and chemotherapy alone for GC. Currently an unmet need is the ...
Neural correlates of posttraumatic stress disorder symptoms, trauma exposure, and postmigration stress in response to fear faces in resettled refugees. Clin. Psychol. Sci. 2019, 27, 811–825. [Google Scholar] [CrossRef] Roberts, B.; Ocaka, K.F.; Browne, J.; Oyok, T.; Sondorp, E. ...